Edesa Biotech EDSA
NASDAQ EDSA
$4.01 -0.20 (-4.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

Edesa Biotech (EDSA) Equity Income (2018)

Updated

Edesa Biotech (EDSA) reported Equity Income of -$46,456 for fiscal Q1 2020 (quarter ended Dec 31, 2018).

Analysis

Edesa Biotech (EDSA) Equity Income (2018) Analysis & Trends

For FY2018 (ended Sep 30, 2018), Edesa Biotech posted Equity Income of -$20,239.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -10.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Edesa Biotech 40.56 Mn 40.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -46,456.00
API Access

Edesa Biotech Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=EDSA&period=max&api_key=YOUR_API_KEY